Probity Advisors, Inc. Edwards Lifesciences Corp Transaction History
Probity Advisors, Inc.
- $588 Million
- Q3 2025
A detailed history of Probity Advisors, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Probity Advisors, Inc. holds 5,090 shares of EW stock, worth $419,670. This represents 0.07% of its overall portfolio holdings.
Number of Shares
5,090
Previous 5,154
1.24%
Holding current value
$419,670
Previous $403,000
1.99%
% of portfolio
0.07%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding EW
# of Institutions
1,457Shares Held
487MCall Options Held
2.76MPut Options Held
1.54M-
Vanguard Group Inc Valley Forge, PA70MShares$5.77 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$4.2 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.6MShares$2.11 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY22MShares$1.81 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA19.8MShares$1.63 Billion0.29% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $51B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...